HU
HUMA
Humacyte, Inc. $0.56 1M +2.0% 3M -46.8% YTD -42.5% as of 2026-09-14↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · earnings ● beat ● miss · ring ◯ before open ◯ after close · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.0%
Next 1 week
-0.4%
Next 1 month
-1.7%
Mean reversion
Deeply oversold — RSI(2) at 7
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.73%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 3.17 -1.5% · Seasonal tilt (5y) -0.3%
$4M/day volume
115% volatility
-63% 1-year
52-week range · 2% of the way up · -78% from the high
$0.53$2.55
Congressional trades in HUMA Full tracker →
1 member · 11 buys / 6 sells · $150K–$550K disclosed · latest filing Aug 5, 2026.
| SELL | $1K–$15K | |
| BUY | $15K–$50K | |
| SELL | $15K–$50K | |
| BUY | $1K–$15K | |
| BUY | $1K–$15K | |
| SELL | $1K–$15K | |
| SELL | $15K–$50K | |
| SELL | $50K–$100K |
Earnings Full history →
Next report 2026-11-12 (Thursday, before open, in 58 days) · EPS est. -0.08.
1-day std dev
13.6%
Finished up
60%
Biggest pop
+31.1%
Biggest drop
-29.6%
Standard deviation of the close-to-close move over the last 20 reports. History, not a forecast.
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.